Iron Therapy (Nutrexin USA)


Welcome to the PulseAid listing for the Iron Therapy drug offered from Nutrexin USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Nutrexin USA
NON-PROPRIETARY NAME: Chininum Arsenicosum, Cuprum Sulphuricum, Ferrum Metallicum, Ferrum Phosphoricum, Zincum Metallicum
SUBSTANCE NAME: QUININE ARSENATE; CUPRIC SULFATE; IRON; FERROSOFERRIC PHOSPHATE; ZINC
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-02-23
END MARKETING DATE: 0000-00-00


Iron Therapy HUMAN OTC DRUG Details:

Item DescriptionIron Therapy from Nutrexin USA
LABELER NAME: Nutrexin USA
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 6; 8; 8; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2015-02-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69173-0001_8059c5e6-0d01-46d0-a2ed-2eea7509b36f
PRODUCT NDC: 69173-0001
APPLICATION NUMBER:

Other QUININE ARSENATE; CUPRIC SULFATE; IRON; FERROSOFERRIC PHOSPHATE; ZINC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Nutrexin USAIron Therapy